47.51
price down icon1.23%   -0.59
after-market Dopo l'orario di chiusura: 47.51
loading
Precedente Chiudi:
$48.10
Aprire:
$47.23
Volume 24 ore:
2.47M
Relative Volume:
1.36
Capitalizzazione di mercato:
$8.31B
Reddito:
$1.17B
Utile/perdita netta:
$150.71M
Rapporto P/E:
50.54
EPS:
0.94
Flusso di cassa netto:
$245.03M
1 W Prestazione:
-9.57%
1M Prestazione:
-21.61%
6M Prestazione:
-32.48%
1 anno Prestazione:
-23.52%
Intervallo 1D:
Value
$46.01
$47.77
Intervallo di 1 settimana:
Value
$46.01
$53.00
Portata 52W:
Value
$46.01
$85.57

Bio Techne Corp Stock (TECH) Company Profile

Name
Nome
Bio Techne Corp
Name
Telefono
(612) 379-8854
Name
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
Dipendente
3,100
Name
Cinguettio
@biotechne
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
TECH's Discussions on Twitter

Confronta TECH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TECH
Bio Techne Corp
47.51 8.31B 1.17B 150.71M 245.03M 0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-09 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2025-03-18 Iniziato Evercore ISI Outperform
2025-02-19 Downgrade Robert W. Baird Outperform → Neutral
2024-05-22 Downgrade Citigroup Buy → Neutral
2024-02-08 Iniziato Scotiabank Sector Outperform
2024-02-02 Downgrade Stifel Buy → Hold
2023-12-07 Iniziato UBS Buy
2023-08-28 Iniziato William Blair Outperform
2023-01-10 Aggiornamento Wells Fargo Underweight → Equal Weight
2022-12-14 Iniziato Deutsche Bank Buy
2022-12-12 Aggiornamento Citigroup Neutral → Buy
2022-12-07 Iniziato RBC Capital Mkts Sector Perform
2022-08-25 Iniziato Credit Suisse Outperform
2022-04-25 Downgrade Wells Fargo Equal Weight → Underweight
2021-09-15 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 Aggiornamento Stephens Equal-Weight → Overweight
2021-02-23 Aggiornamento Stifel Hold → Buy
2021-01-25 Reiterato The Benchmark Company Buy
2020-11-10 Iniziato KeyBanc Capital Markets Sector Weight
2020-09-30 Iniziato Atlantic Equities Overweight
2020-07-15 Downgrade Stephens Overweight → Equal-Weight
2020-05-27 Downgrade Stifel Buy → Hold
2020-05-14 Iniziato The Benchmark Company Buy
2020-01-08 Ripresa Stephens Overweight
2020-01-08 Iniziato Wells Fargo Equal Weight
2020-01-07 Iniziato Citigroup Neutral
2019-11-15 Iniziato Stifel Buy
2019-07-02 Aggiornamento Janney Neutral → Buy
2019-01-14 Aggiornamento Stephens Equal-Weight → Overweight
2018-10-31 Downgrade Craig Hallum Buy → Hold
2018-10-17 Iniziato Goldman Neutral
2018-06-15 Iniziato Argus Buy
2017-07-13 Iniziato Wells Fargo Market Perform
2017-02-09 Iniziato Citigroup Buy
2017-01-18 Iniziato Deutsche Bank Buy
2016-11-10 Ripresa Leerink Partners Outperform
2015-01-21 Reiterato Robert W. Baird Outperform
2013-09-20 Aggiornamento Robert W. Baird Neutral → Outperform
Mostra tutto

Bio Techne Corp Borsa (TECH) Ultime notizie

pulisher
08:00 AM

Former Novartis Deal Chief Who Led 50+ Strategic Transactions Joins OmniAb Board - Stock Titan

08:00 AM
pulisher
Apr 17, 2025

Leerink Partners Adjusts Price Target on Bio-Techne to $80 From $95, Keeps Outperform Rating - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS - Quantisnow

Apr 17, 2025
pulisher
Apr 16, 2025

Bio-Techne Stock Set to Benefit From Expansion of RNAscope Menu - MSN

Apr 16, 2025
pulisher
Apr 15, 2025

Bio-Techne Sets Date for Q3 2025 Financial Results: Key Details for Investors - Stock Titan

Apr 15, 2025
pulisher
Apr 10, 2025

Strength Seen in Bio-Techne (TECH): Can Its 10.8% Jump Turn into More Strength? - Yahoo Finance

Apr 10, 2025
pulisher
Apr 10, 2025

Bio-Techne (TECH) Faces Downgrade Amid NIH Funding Concerns - GuruFocus

Apr 10, 2025
pulisher
Apr 09, 2025

Forecasting The Future: 6 Analyst Projections For Bio-Techne - Benzinga

Apr 09, 2025
pulisher
Apr 09, 2025

This PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga

Apr 09, 2025
pulisher
Apr 09, 2025

Bio-Techne stock downgraded at KeyBanc (TECH:NASDAQ) - Seeking Alpha

Apr 09, 2025
pulisher
Apr 09, 2025

KeyBanc Downgrades Bio-Techne to Sector Weight From Overweight - MarketScreener

Apr 09, 2025
pulisher
Apr 09, 2025

KeyBanc cuts Bio-Techne stock rating on funding concerns By Investing.com - Investing.com India

Apr 09, 2025
pulisher
Apr 09, 2025

KeyBanc cuts Bio-Techne stock rating on funding concerns - Investing.com

Apr 09, 2025
pulisher
Apr 08, 2025

Trading (TECH) With Integrated Risk Controls - news.stocktradersdaily.com

Apr 08, 2025
pulisher
Apr 08, 2025

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.

Apr 08, 2025
pulisher
Apr 04, 2025

Spatial Genomics and Transcriptomics Industry Analysis Report 2025, Featuring Detailed Profiles of Leading Players10x Genomics, Bruker Corp., Akoya Biosciences, and Bio-Techne Among OthersResearchAndMarkets.com - Bluefield Daily Telegraph

Apr 04, 2025
pulisher
Apr 03, 2025

Techne Corp stock hits 52-week low at $56.58 amid market shifts - Investing.com

Apr 03, 2025
pulisher
Apr 02, 2025

Bio-Techne Expands Collaboration With Leica To Enhance Spatial Multiomics Research Capabilities - Nasdaq

Apr 02, 2025
pulisher
Apr 02, 2025

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument - PR Newswire

Apr 02, 2025
pulisher
Apr 02, 2025

Evercore ISI Adjusts Bio-Techne Price Target to $70 From $75, Maintains Outperform Rating - marketscreener.com

Apr 02, 2025
pulisher
Apr 01, 2025

Is Bio-Techne Corporation Stock Underperforming the S&P 500? - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

Is Bio-Techne Corporation Stock Underperforming The S&P 500? - Barchart.com

Apr 01, 2025
pulisher
Apr 01, 2025

Exosomes Market Detailed In New Research Report 2025 | Thermo Fisher Scientific, Inc., Bio-Techne, QIAGEN, Lonza - openPR.com

Apr 01, 2025
pulisher
Mar 31, 2025

Bio-Techne Opens New Customer Experience Centre in Germany - Nasdaq

Mar 31, 2025
pulisher
Mar 31, 2025

3 Reasons to Avoid TECH and 1 Stock to Buy Instead - Yahoo Finance

Mar 31, 2025
pulisher
Mar 30, 2025

11 Best Gene Therapy Stocks to Buy According to Analysts - Insider Monkey

Mar 30, 2025
pulisher
Mar 28, 2025

Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch - Yahoo Finance

Mar 28, 2025
pulisher
Mar 26, 2025

Bio-Techne to Open New Customer Facility in Germany - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Bio-Techne's New Tech Hub Targets Major European Life Sciences Growth - Stock Titan

Mar 26, 2025
pulisher
Mar 24, 2025

Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - Quantisnow

Mar 24, 2025
pulisher
Mar 24, 2025

Game-Changing Cancer Detection Technology: RNAscope Shows Superior Results in Multiple Tumors - Stock Titan

Mar 24, 2025
pulisher
Mar 19, 2025

Bio-Techne Earnings Preview: What to Expect - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

Evercore ISI Group Initiates Coverage of Bio-Techne (TECH) with Outperform Recommendation - MSN

Mar 19, 2025
pulisher
Mar 18, 2025

Evercore ISI sets Bio-Techne stock Outperform with $75 target By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

6 Analysts Assess Bio-Techne: What You Need To Know - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Evercore ISI sets Bio-Techne stock Outperform with $75 target - Investing.com

Mar 18, 2025
pulisher
Mar 17, 2025

Bio-Techne: A Premium Growth Asset with Strong Market Position and Promising Future - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

Bio-Techne (NASDAQ:TECH) shareholders have earned a 8.3% CAGR over the last five years - Yahoo Finance

Mar 17, 2025
pulisher
Mar 14, 2025

Bio-Techne (NASDAQ:TECH) Downgraded by StockNews.com to "Hold" - MarketBeat

Mar 14, 2025
pulisher
Mar 13, 2025

Bio-Techne Co. (NASDAQ:TECH) Receives $82.14 Consensus Price Target from Analysts - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.

Mar 12, 2025
pulisher
Mar 12, 2025

Bio Techne at Barclays Conference: Strategic Growth Amid Market Challenges - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

TECH Stock Might Rise Following the Leo Shipping Announcement - Nasdaq

Mar 12, 2025
pulisher
Mar 11, 2025

Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch

Mar 11, 2025
pulisher
Mar 11, 2025

Bio-Techne at Leerink’s Global Healthcare Conference: Strategic Growth Amid Challenges - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Techne Corp stock hits 52-week low at $58.94 amid market shifts - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Techne Corp stock hits 52-week low at $58.94 amid market shifts By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

GC Wealth Management RIA LLC Takes $805,000 Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Mar 11, 2025
pulisher
Mar 10, 2025

Bio-Techne Corp (TECH) Q1 FY2025 Earnings: Revenue Surpasses Est - GuruFocus.com

Mar 10, 2025
pulisher
Mar 10, 2025

Bio-Techne Begins Shipping LeoA Next Generation High-Throughput Simple Western System - Quantisnow

Mar 10, 2025
pulisher
Mar 10, 2025

Bio-Techne launches high-throughput Leo System - Investing.com

Mar 10, 2025

Bio Techne Corp Azioni (TECH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Capitalizzazione:     |  Volume (24 ore):